Parkinson Disease
2,451
417
511
1,195
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
254 trials with published results (10%)
Research Maturity
1195 completed trials (49% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.8%
118 terminated out of 2451 trials
91.0%
+4.5% vs benchmark
5%
133 trials in Phase 3/4
21%
254 of 1195 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1195 completed trials
Clinical Trials (2451)
Effects of RAS on Gait in PD Patients With DBS
A Prospective, Randomized, Controlled Trial to Test Safety and Effectiveness of Unilateral Exablate MR-guided Focused Ultrasound Subthalamotomy in Patients With Early-Stage Parkinson's Disease
Therapeutic Education in Parkinson's Disease: What Impact on Drug Representations of Patients? (ETPARK-REMED)
Combined Deep Brain Stimulation in Parkinson's Disease
Functional Neuroimaging in Parkinson's Disease
Deep Brain Stimulation (DBS) Retrospective Outcomes Study
Safety and Tolerability of Patterned Stimulation for DBS in the Home Setting
Accelerated Temporal Interference Stimulation on Bilateral Subthalamic Nucleus for Parkinson's Disease and Secondary Parkinson's Syndrome
Reliability and Validity of Sensor-derived Measurements in Individuals With Parkinson's Disease: Preliminary Results From the INERTIAL Study
Deep Brain Stimulation in Parkinson's Disease: Motor and Functional Outcomes
Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients
Aquatic High-Intensity Interval Training for Parkinson's Disease
A Study of AB-1005 Gene Therapy in Japanese Adults With Moderate Parkinson's Disease
REal-life ON PARKinson's - ITaly (REONPARK-IT)
Robotic Gait Rehabilitation in Parkinson's Disease
" Visual Characterization of Parkinson's Patients and Oculomotor or Perceptual Therapy"
Effects of PR Oxycodone and of Levodopa, vs Placebo, on Central Neuropathic Pain in Parkinson's Disease
Evaluation of Neuroinflammation in Parkinson's Disease Using 18F-NOS PET/CT
Adaptive Deep Brain Stimulation to Improve Motor and Gait Functions in Parkinson's Disease
Direct Measurement of Motor Cortical Responses to tDCS